IDH1 and central nervous system cancer: The 2021 World Health Organization (WHO) Classification of Tumors of the Central Nervous System (CNS) defines gliomas by their molecular genetic alterations, such as IDH1/2 mutations and 1p/19q co-deletion (1, 2).